Introduction
============

The global cancer burden has risen to 18.1 million cases and 9.6 million cancer deaths in 2018 \[[@b1-crt-2019-138]\]. Cancer incidence and mortality are rapidly growing worldwide. The reasons are complex but reflect both aging and growth of the population, as well as changes in the prevalence and distribution of the main risk factors for cancer \[[@b2-crt-2019-138]\].

In Korea, cancer accounts for one in four deaths and more than 200,000 new cancer cases were diagnosed in 2015 \[[@b3-crt-2019-138]\]. The number of cancer incidences and deaths are expected to increase with an aging population and westernized lifestyles \[[@b4-crt-2019-138]\].

In this context, cancer statistics are the most important indicator to assess the national cancer burden, which can be used to establish cancer control strategies. This article aimed to provide nationwide cancer statistics including incidence, survival, prevalence, and mortality in 2016.

Materials and Methods
=====================

1. Data sources
---------------

The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980 as a nationwide hospital-based cancer registry. Since 1999, the KCCR has collected cancer incidence data nationwide by integrating a nationwide hospital-based KCCR database with data from regional cancer registries. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually \[[@b5-crt-2019-138]\].

The KCCR built the Korea National Cancer Incidence Database (KNCI DB) from hospitals, 11 population-based registries, and additional medical record reviews. The KNCI DB contains information regarding age, sex, region, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, summary stage of surveillance, epidemiology and end results program (SEER) and first course of treatment within four months after diagnosis. The completeness of cancer incidence data for 2016 was estimated to be 98.2% based on the method proposed by Ajiki et al. \[[@b6-crt-2019-138]\]. The mid-year population and cancer mortality data from 1983 to 2016 were obtained from Statistics Korea \[[@b7-crt-2019-138]\]. To ascertain vital status and to calculate survival and prevalence, the KNCI DB was linked to mortality data and population registration data from the Ministry of the Interior.

2. Classification
-----------------

All incidence cases were registered according to the International Classification of Diseases for Oncology, third edition \[[@b8-crt-2019-138]\] and converted to the International Classification of Diseases, 10th edition (ICD-10) \[[@b9-crt-2019-138]\]. The mortality cases were registered according to ICD-10. All cancer cases were reported based on the 24 cancer types.

3. Statistical analyses
-----------------------

Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The CR was calculated as the total number of incidence/mortality cases divided by the mid-year population of the specified years. The ASR is a weighted average of the age-specific rates, where the weights are the proportions of persons in the corresponding age groups of a standard population \[[@b10-crt-2019-138]\]. In this report, ASRs were calculated using Segi's world standard population \[[@b11-crt-2019-138]\]. The cumulative risk of developing cancer from birth to life expectancy was calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows \[[@b12-crt-2019-138]\]:
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Trends in ASRs were summarized as an annual percentage change (APC) by using a Joinpoint regression. APC is the average percentage change of ASRs and is calculated as follows \[[@b10-crt-2019-138]\]:
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, where log(*R*~y~)=*b*~0~+*b*~1y~,

log(*R*~y~) is the natural log transformed age standardized rates.

y=year, *b*~0~=intercept, *b*~1~=slope

The survival duration for each cancer case was determined as the interval between the date of initial diagnosis and the date of death, date of loss of follow-up, or closing date for follow-up, whichever came first. The 5-year relative survival rate was calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year relative survival rates were evaluated as percentage differences in 5-year relative survival rates from 1993-1995 and 2012-2016. Relative survival rates were calculated using the Ederer II method \[[@b13-crt-2019-138]\] with some minor corrections, based on an algorithm by Paul Dickman \[[@b14-crt-2019-138]\].

Prevalent cases were defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed between 1999 and 2016. Limited-duration prevalences were calculated using SEER\*Stat software. Any p-values less than 0.05 were considered statistically significant. SEER\*Stat 8.1.2 (National Cancer Institute, Bethesda, MD), Joinpoint 4. 1. 1 (National Cancer Institute), and SAS ver. 9.4 (SAS Institute, Cary, NC) were used for statistical analysis.

Selected Findings
=================

1. Incidence
------------

A total of 229,180 cancer cases were newly diagnosed in 2016, which included 120,068 men (52.4%) and 109,112 women (47.6%) ([Table 1](#t1-crt-2019-138){ref-type="table"}). Stomach cancer was the most commonly diagnosed cancer in 2016, followed by colorectal, thyroid, lung, and breast cancer. The overall cumulative risk of developing cancer from birth to life expectancy was 36.2%. The cumulative risk of developing cancer from birth to life expectancy was higher in men (38.3%) than in women (33.3%) (data not shown).

The total CR and ASR for overall cancer incidences in 2016 were 448.4 and 269.0 per 100,000, respectively ([Table 2](#t2-crt-2019-138){ref-type="table"}). According to sex, CRs for all sites combined were 470.3 per 100,000 in men and 426.5 per 100,000 in women. The ASRs were 298.0 and 254.6 per 100,000 in men and women, respectively. Stomach cancer (CR, 80.3 per 100,000) was the most common cancer in men, followed by lung (CR, 69.7 per 100,000), colorectal (CR, 65.3 per 100,000), prostate (CR, 46.2 per 100,000), and liver cancer (CR, 46.1 per 100,000). These five cancers accounted for 65.4% of newly diagnosed cases in men during the study period. In contrast, breast cancer (CR, 85.0 per 100,000) was the most common cancer among women, followed by thyroid (CR, 80.2 per 100,000), colorectal (CR, 44.8 per 100,000), stomach (CR, 39.1 per 100,000), and lung cancer (CR, 31.2 per 100,000). These five cancers accounted for 65.7% of cases in women.

2. Mortality
------------

The total number of deaths from cancer in 2016 was 78,194, accounting for 27.8% of all deaths ([Table 3](#t3-crt-2019-138){ref-type="table"}). According to sex, 61.7% and 38.3% of cancer deaths occurred in men and women, respectively ([Table 1](#t1-crt-2019-138){ref-type="table"}).

The total CR and ASR for cancer deaths were 153.0 and 79.8 per 100,000, respectively, in 2016 ([Table 4](#t4-crt-2019-138){ref-type="table"}). The total CR and ASR for cancer deaths per 100,000 were higher among men (CR, 188.8; ASR, 115.5) than in women (CR, 117.2; ASR, 53.6).

According to the cancer sites, lung cancer (CR, 52.2 per 100,000) was the leading cause of death in men, followed by liver (CR, 31.5 per 100,000), stomach (CR, 20.8 per 100,000), colorectal (CR, 18.3 per 100,000), and pancreatic cancer (CR, 11.4 per 100,000). The top five causes of deaths from cancer in women included lung (CR, 18.1 per 100,000), colorectal (CR, 14.5 per 100,000), liver (CR, 11.6 per 100,000), stomach (CR, 11.5 per 100,000), and pancreatic cancer (CR, 10.6 per 100,000).

3. Trends in cancer incidence and mortality
-------------------------------------------

[Fig. 1](#f1-crt-2019-138){ref-type="fig"} shows trends in cancer incidence and mortality from 1983 to 2016. The ASR for all-cancer incidence increased by 3.6% annually from 1999 to 2011, and then started to decrease from 2011 to 2016 (APC, --3.1%) ([Table 5](#t5-crt-2019-138){ref-type="table"}). Cases of stomach, colorectum, lung, and thyroid cancers started to decrease around 2011. Specifically, ASR for thyroid cancer increased rapidly to 22.6% from 1999 to 2011, but then decreased swiftly by 12.6% annually starting in 2011. The incidence of breast cancer increased constantly throughout the period; however, the APC slowed from 2005 onward. Conversely, the incidence rates of cervix and liver showed a constant decrease for the whole period. Thyroid cancer decreased the most drastically starting in the early 2010s ([Fig. 2](#f2-crt-2019-138){ref-type="fig"}).

The ASR for all-cancer mortality rate increased until 2002 ([Table 6](#t6-crt-2019-138){ref-type="table"}). After that year, it started to decrease (2002-2016; APC, --2.7%). The same patterns were evident in men and women. Cancer incidence at most sites, including the cervix uteri, thyroid, liver, gallbladder, lung, brain and central nervous system, and colorectum started to decrease in the early 2000s. Furthermore, cancers of the lips, oral cavity and pharynx, esophagus, stomach, larynx, and non-Hodgkin lymphoma decreased from 1999. Breast cancer showed constant increasing trends for the whole period ([Fig. 3](#f3-crt-2019-138){ref-type="fig"}).

4. Age-specific incidence rates
-------------------------------

Leukemia was the most commonly diagnosed cancer among children between 0-14 years of age. Thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age ([Table 7](#t7-crt-2019-138){ref-type="table"}). Stomach cancer was the most commonly diagnosed cancer among men aged 35 to 64 years, while lung cancer was the most common among men aged 65 years and above ([Fig. 4A](#f4-crt-2019-138){ref-type="fig"}). In contrast, breast cancer was the most commonly diagnosed cancer among women aged 35 to 64 years, while colorectal cancer was the most common among women aged 65 years and above. Thyroid and breast cancers showed an inverted U-shaped incidence rate by age ([Fig. 4B](#f4-crt-2019-138){ref-type="fig"}).

5. Survival rates
-----------------

The 5-year relative survival rates for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 70.6% in 2012-2016 ([Table 8](#t8-crt-2019-138){ref-type="table"}). After excluding thyroid cancer, the 5-year relative survival rates for all cancer still increased from 1999 to 2016 ([Fig. 5B](#f5-crt-2019-138){ref-type="fig"}).

The 5-year relative survival rate during 2012-2016 for all cancer combined was 63.2% in men and 78.0% in women, respectively. The 5-year relative survival rate for thyroid cancer was over 100%, while the 5-year relative survival rates for testis, prostate, and breast cancer were over 90% in 2012-2016 for both sexes, respectively. However, the 5-year relative survival rate for pancreatic cancer was only 11.4% in both sexes in 2012-2016.

When compared to the 5-year relative survival rate for men in 1993-1995, prostate cancer diagnosed from 2012 to 2016 showed the most outstanding improvement, followed by stomach, leukemia, 'lip, oral cavity, and pharynx,' esophagus and liver cancer. Among women, stomach cancer diagnosed during 2012-2016 showed the greatest improvement in 5-year relative survival rates compared to those between 1993 and 1995, followed by lung, leukemia, multiple myeloma, liver, and colorectal cancer.

6. Prevalence rates
-------------------

A total of 1,739,951 cancer prevalent cases were identified on January 1, 2017 ([Table 1](#t1-crt-2019-138){ref-type="table"}). Of these cases, 764,103 (43.9%) were men and 975,848 (56.1%) were women. The overall CR and ASR for cancer prevalence were 3,404.1 per 100,000 individuals and 2,046.2 per 100,000 individuals for both sexes, respectively, in 2016 ([Table 9](#t9-crt-2019-138){ref-type="table"}).

The five most common cancers for men were stomach (CR, 709.9 per 100,000), colorectal (CR, 551.8 per 100,000), prostate (CR, 304.1 per 100,000), thyroid (CR, 255.9 per 100,000), and liver cancer (CR, 190.6 per 100,000). In contrast, thyroid cancer was most common in women (CR, 1,229.7 per 100,000), followed by breast (CR, 771.0 per 100,000), colorectal (CR, 373.6 per 100,000), stomach (CR, 361.4 per 100,000), and cervix uteri cancer (CR, 206.2 per 100,000).

Analysis of the period after cancer diagnosis revealed that stomach cancer (14.1%) was the most prevalent cancer within 2 years after diagnosis, followed by thyroid (14.0%) and colorectal cancer (13.1%) ([Fig. 6](#f6-crt-2019-138){ref-type="fig"}). Thyroid cancer (25.5%) was most prevalent for 2-5 years, followed by stomach (14.3%) and colorectal cancer (13.4%). After 5 years, thyroid cancer (23.1%) was the most prevalent cancer, followed by stomach (17.1%) and colorectal cancer (13.9%).
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###### 

Cancer incidence, deaths, and prevalence by sex in Korea, 2016

  Site/Type                                                    New cases   Deaths    Prevalent cases^[a)](#tfn1-crt-2019-138){ref-type="table-fn"}^                                                    
  ------------------------------------------------------------ ----------- --------- ---------------------------------------------------------------- -------- -------- -------- ----------- --------- ---------
  All sites                                                    229,180     120,068   109,112                                                          78,194   48,208   29,986   1,739,951   764,103   975,848
  Lip, oral cavity, and pharynx                                3,543       2,527     1,016                                                            1,203    909      294      23,639      15,847    7,792
  Esophagus                                                    2,499       2,245     254                                                              1,524    1,379    145      9,777       8,780     997
  Stomach                                                      30,504      20,509    9,995                                                            8,264    5,318    2,946    273,701     181,234   92,467
  Colon and rectum                                             28,127      16,672    11,455                                                           8,358    4,659    3,699    236,431     140,852   95,579
  Liver                                                        15,771      11,774    3,997                                                            11,001   8,044    2,957    64,864      48,666    16,198
  Gallbladder^[b)](#tfn2-crt-2019-138){ref-type="table-fn"}^   6,685       3,490     3,195                                                            4,408    2,248    2,160    21,011      10,776    10,235
  Pancreas                                                     6,655       3,384     3,271                                                            5,614    2,901    2,713    10,595      5,502     5,093
  Larynx                                                       1,167       1,101     66                                                               334      310      24       10,532      9,914     618
  Lung                                                         25,780      17,790    7,990                                                            17,963   13,324   4,639    76,544      47,438    29,106
  Breast                                                       21,839      92        21,747                                                           2,472    16       2,456    198,006     743       197,263
  Cervix uteri                                                 3,566       \-        3,566                                                            897      \-       897      52,758      \-        52,758
  Corpus uteri                                                 2,771       \-        2,771                                                            313      \-       313      23,135      \-        23,135
  Ovary                                                        2,630       \-        2,630                                                            1,204    \-       1,204    19,509      \-        19,509
  Prostate                                                     11,800      11,800    \-                                                               1,745    1,745    \-       77,635      77,635    \-
  Testis                                                       288         288       \-                                                               14       14       \-       3,204       3,204     \-
  Kidney                                                       5,043       3,410     1,633                                                            1,032    724      308      38,836      26,161    12,675
  Bladder                                                      4,361       3,488     873                                                              1,389    1,029    360      33,543      27,347    6,196
  Brain and CNS                                                2,015       1,104     911                                                              1,327    720      607      11,116      5,734     5,382
  Thyroid                                                      26,051      5,538     20,513                                                           346      104      242      379,946     65,336    314,610
  Hodgkin lymphoma                                             312         202       110                                                              51       33       18       2,807       1,770     1,037
  Non-Hodgkin lymphoma                                         4,766       2,766     2,000                                                            1,820    1,068    752      30,093      17,130    12,963
  Multiple myeloma                                             1,535       837       698                                                              1,010    527      483      5,798       3,050     2,748
  Leukemia                                                     3,416       1,991     1,425                                                            1,842    1,025    817      20,751      11,553    9,198
  Other and ill-defined                                        18,056      9,060     8,996                                                            4,063    2,111    1,952    115,720     55,431    60,289

CNS, central nervous system.

Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2016 and who were alive on January 1, 2017. Multiple primary cancer cases were counted multiple times,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized cancer incidence rates by sex in Korea, 2016

  Site/Type                                                    Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn3-crt-2019-138){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    448.4                              470.3                                                                                        426.5   269.0   298.0   254.6
  Lip, oral cavity, and pharynx                                6.9                                9.9                                                                                          4.0     4.2     6.4     2.3
  Esophagus                                                    4.9                                8.8                                                                                          1.0     2.7     5.4     0.5
  Stomach                                                      59.7                               80.3                                                                                         39.1    34.0    49.6    20.5
  Colon and rectum                                             55.0                               65.3                                                                                         44.8    30.7    40.4    22.4
  Liver                                                        30.9                               46.1                                                                                         15.6    17.6    28.5    7.8
  Gallbladder^[b)](#tfn4-crt-2019-138){ref-type="table-fn"}^   13.1                               13.7                                                                                         12.5    6.7     8.3     5.5
  Pancreas                                                     13.0                               13.3                                                                                         12.8    7.0     8.1     6.0
  Larynx                                                       2.3                                4.3                                                                                          0.3     1.3     2.6     0.1
  Lung                                                         50.4                               69.7                                                                                         31.2    27.1    42.3    15.4
  Breast                                                       42.7                               0.4                                                                                          85.0    27.7    0.2     54.9
  Cervix uteri                                                 7.0                                0.0                                                                                          13.9    4.6     \-      9.1
  Corpus uteri                                                 5.4                                0.0                                                                                          10.8    3.4     \-      6.8
  Ovary                                                        5.1                                0.0                                                                                          10.3    3.4     \-      6.7
  Prostate                                                     23.1                               46.2                                                                                         0.0     12.5    28.2    \-
  Testis                                                       0.6                                1.1                                                                                          0.0     0.6     1.1     \-
  Kidney                                                       9.9                                13.4                                                                                         6.4     6.1     8.7     3.8
  Bladder                                                      8.5                                13.7                                                                                         3.4     4.5     8.4     1.6
  Brain and CNS                                                3.9                                4.3                                                                                          3.6     3.1     3.5     2.7
  Thyroid                                                      51.0                               21.7                                                                                         80.2    36.6    15.6    58.1
  Hodgkin lymphoma                                             0.6                                0.8                                                                                          0.4     0.5     0.6     0.4
  Non-Hodgkin lymphoma                                         9.3                                10.8                                                                                         7.8     6.2     7.7     4.8
  Multiple myeloma                                             3.0                                3.3                                                                                          2.7     1.7     2.0     1.4
  Leukemia                                                     6.7                                7.8                                                                                          5.6     5.6     6.6     4.7
  Other and ill-defined                                        35.3                               35.5                                                                                         35.2    21.2    23.7    19.1

CNS, central nervous system.

Age-adjusted using the Segi's world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The top 10 leading causes of death in Korea, 2016

  Rank   Cause of death                       No. of deaths (%)   Age-standardized death rate per 100,000^[a)](#tfn5-crt-2019-138){ref-type="table-fn"}^
  ------ ------------------------------------ ------------------- ----------------------------------------------------------------------------------------
         All causes                           280,827 (100)       280.8
  1      Cancer                               78,194 (27.8)       79.8
  2      Heart disease                        9,807 (3.5)         9.0
  3      Cerebrovascular disease              5,416 (1.9)         4.6
  4      Pneumonia                            29,735 (10.6)       27.8
  5      Intentional self-harm (suicide)      23,415 (8.3)        21.4
  6      Diabetes mellitus                    16,476 (5.9)        14.3
  7      Chronic lower respiratory diseases   6,992 (2.5)         6.0
  8      Disease of liver                     6,798 (2.4)         7.7
  9      Transport accidents                  5,150 (1.8)         6.8
  10     Hypertensive diseases                13,092 (4.7)        17.7
         Others                               85,752 (30.5)       85.9

Source: Mortality Data, 2016, Statistics Korea \[1\].

Age-adjusted using the Segi's world standard population.

###### 

Crude and age-standardized cancer mortality rates by sex in Korea, 2016

  Site/Type                                                    Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn6-crt-2019-138){ref-type="table-fn"}^                          
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                    153.0                              188.8                                                                                        117.2   79.8   115.5   53.6
  Lip, oral cavity, and pharynx                                2.4                                3.6                                                                                          1.1     1.3    2.2     0.5
  Esophagus                                                    3.0                                5.4                                                                                          0.6     1.6    3.2     0.2
  Stomach                                                      16.2                               20.8                                                                                         11.5    8.3    12.7    5.0
  Colon and rectum                                             16.4                               18.3                                                                                         14.5    8.2    11.1    5.9
  Liver                                                        21.5                               31.5                                                                                         11.6    11.7   19.2    5.2
  Gallbladder^[b)](#tfn7-crt-2019-138){ref-type="table-fn"}^   8.6                                8.8                                                                                          8.4     4.2    5.3     3.4
  Pancreas                                                     11.0                               11.4                                                                                         10.6    5.7    7.0     4.6
  Larynx                                                       0.7                                1.2                                                                                          0.1     0.3    0.8     0.0
  Lung                                                         35.1                               52.2                                                                                         18.1    17.6   31.2    7.7
  Breast                                                       4.8                                0.1                                                                                          9.6     2.9    0.0     5.5
  Cervix uteri                                                 1.8                                0.0                                                                                          3.5     1.0    \-      1.8
  Corpus uteri                                                 0.6                                0.0                                                                                          1.2     0.4    \-      0.7
  Ovary                                                        2.4                                0.0                                                                                          4.7     1.3    \-      2.5
  Prostate                                                     3.4                                6.8                                                                                          0.0     1.5    4.2     \-
  Testis                                                       0.0                                0.1                                                                                          0.0     0.0    0.0     \-
  Kidney                                                       2.0                                2.8                                                                                          1.2     1.1    1.8     0.5
  Bladder                                                      2.7                                4.0                                                                                          1.4     1.3    2.5     0.5
  Brain and CNS                                                2.6                                2.8                                                                                          2.4     1.7    2.0     1.4
  Thyroid                                                      0.7                                0.4                                                                                          0.9     0.3    0.2     0.4
  Hodgkin lymphoma                                             0.1                                0.1                                                                                          0.1     0.1    0.1     0.0
  Non-Hodgkin lymphoma                                         3.6                                4.2                                                                                          2.9     1.9    2.6     1.4
  Multiple myeloma                                             2.0                                2.1                                                                                          1.9     1.0    1.2     0.9
  Leukemia                                                     3.6                                4.0                                                                                          3.2     2.3    2.8     1.9
  Other and ill-defined                                        7.9                                8.3                                                                                          7.6     4.3    5.3     3.5

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates from 1999 to 2016 in Korea

  Site/Type                                                    Both sexes   Men     Women                                                                                                                                                                                                                                                                                                                                                                                        
  ------------------------------------------------------------ ------------ ------- ----------- ------------------------------------------------------ ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------ ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------ ----------- -------------------------------------------------------
  All sites                                                    210.5        269.0   1999-2011   3.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2011-2016   --3.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    285.0   298.0   1999-2011   1.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2011-2016   --3.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    161.1   254.6   1999-2011   5.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2011-2016   --3.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                3.6          4.2     1999-2016   0.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      6.1     6.4     1999-2016   --0.1                                                  \-          \-                                                      1.6     2.3     1999-2016   1.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-
  Esophagus                                                    4.1          2.7     1999-2016   --2.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      8.8     5.4     1999-2016   --2.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      0.6     0.5     1999-2016   --1.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-
  Stomach                                                      43.6         34.0    1999-2011   --0.2                                                  2011-2016   --4.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    66.2    49.6    1999-2011   --0.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   2011-2016   --5.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    26.7    20.5    1999-2011   --0.4                                                  2011-2016   --4.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Colon and rectum                                             20.4         30.7    1999-2010   6.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2010-2016   --4.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    26.2    40.4    1999-2010   6.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2010-2016   --5.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    16.4    22.4    1999-2010   4.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2010-2016   --3.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Liver                                                        27.9         17.6    1999-2010   --1.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   2010-2016   --4.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    46.8    28.5    1999-2009   --1.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   2009-2016   --4.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    12.3    7.8     1999-2010   --1.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   2010-2016   --4.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn9-crt-2019-138){ref-type="table-fn"}^   6.5          6.7     1999-2004   1.5                                                    2004-2016   --0.3                                                   8.1     8.3     1999-2016   0.1                                                    \-          \-                                                      5.4     5.5     1999-2003   2.4                                                    2003-2016   --0.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Pancreas                                                     5.6          7.0     1999-2016   1.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      7.8     8.1     1999-2016   0.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      4.0     6.0     1999-2016   2.3^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-
  Larynx                                                       2.3          1.3     1999-2016   --3.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      4.9     2.6     1999-2016   --3.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      0.4     0.1     1999-2007   --9.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   2007-2016   --4.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Lung                                                         28.5         27.1    1999-2011   0.1                                                    2011-2016   --1.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    51.4    42.3    1999-2005   --0.1                                                  2005-2016   --1.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    12.4    15.4    1999-2011   2.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2011-2016   --0.1
  Breast                                                       10.7         27.7    1999-2005   7.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2005-2016   4.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^      0.2     0.2     1999-2016   --0.8                                                                                                                      20.9    54.9    1999-2005   7.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2005-2016   4.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Cervix uteri                                                 8.5          4.6     1999-2016   --3.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      \-      \-      \-          \-                                                     \-          \-                                                      16.3    9.1     1999-2016   --3.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   \-          \-
  Corpus uteri                                                 1.4          3.4     1999-2003   8.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2003-2016   4.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^      \-      \-      \-          \-                                                     \-          \-                                                      2.8     6.8     1999-2003   9.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2003-2016   4.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Ovary                                                        2.7          3.4     1999-2016   1.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      \-      \-      \-          \-                                                     \-          \-                                                      5.0     6.7     1999-2016   1.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-
  Prostate                                                     3.1          12.5    1999-2009   15.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    2009-2016   1.0                                                     8.4     28.2    1999-2009   13.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    2009-2016   0.2                                                     \-      \-      \-          \-                                                     \-          \-
  Testis                                                       0.3          0.6     1999-2016   4.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      0.6     1.1     1999-2016   4.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      \-      \-      \-          \-                                                     \-          \-
  Kidney                                                       3.0          6.1     1999-2009   6.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2009-2016   1.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^      4.5     8.7     1999-2010   6.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2010-2016   0.8                                                     1.7     3.8     1999-2008   6.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2008-2016   2.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Bladder                                                      4.6          4.5     1999-2004   2.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2004-2016   --1.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    9.0     8.4     1999-2004   2.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2004-2016   --1.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    1.6     1.6     1999-2003   2.2                                                    2003-2016   --1.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Brain and CNS                                                2.9          3.1     1999-2016   0.2                                                    \-          \-                                                      3.2     3.5     1999-2016   0.3                                                    \-          \-                                                      2.6     2.7     1999-2016   0.1                                                    \-          \-
  Thyroid                                                      6.3          36.6    1999-2011   22.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    2011-2016   --12.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   2.1     15.6    1999-2012   22.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    2012-2016   --14.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^   10.4    58.1    1999-2011   22.3^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^    2011-2016   --13.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Hodgkin lymphoma                                             0.2          0.5     1999-2016   4.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      0.4     0.6     1999-2016   3.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      0.1     0.4     1999-2016   5.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-
  Non-Hodgkin lymphoma                                         4.3          6.2     1999-2016   2.4^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      5.6     7.7     1999-2016   2.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      3.3     4.8     1999-2016   2.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-
  Multiple myeloma                                             1.0          1.7     1999-2012   3.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2012-2016   0.8                                                     1.2     2.0     1999-2012   3.5^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2012-2016   0.5                                                     0.8     1.4     1999-2006   6.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2006-2016   2.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^
  Leukemia                                                     4.7          5.6     1999-2016   1.0^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      5.5     6.6     1999-2016   1.1^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      3.9     4.7     1999-2016   0.8^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-
  Other and ill-defined                                        14.4         21.2    1999-2007   3.6^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2007-2016   1.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^      18.1    23.7    1999-2016   1.9^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      11.9    19.1    1999-2008   4.2^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^     2008-2016   1.7^[a)](#tfn8-crt-2019-138){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the Segi's world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer mortality rates from 1999 to 2016 in Korea

  Site/Type                                                     Both sexes   Men    Women                                                                                                                                                                                                                                                                                                                                                                                          
  ------------------------------------------------------------- ------------ ------ ----------- ------------------------------------------------------- ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------- ----------- ------------------------------------------------------- ------ ------ ----------- -------------------------------------------------------- ----------- -------------------------------------------------------
  All sites                                                     114.3        79.8   1999-2002   1.1                                                     2002-2016   --2.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   176.6   115.5   1999-2002   1.3                                                     2002-2016   --3.2^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   70.6   53.6   1999-2002   1.0                                                      2002-2016   --2.2^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                 1.1          1.3    1999-2016   --1.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      2.0     2.2     1999-2016   --2.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      0.4    0.5    1999-2016   --2.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    \-          \-
  Esophagus                                                     3.1          1.6    1999-2016   --4.3^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      6.8     3.2     1999-2016   --4.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      0.5    0.2    1999-2010   --6.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2010-2016   --0.6
  Stomach                                                       23.8         8.3    1999-2003   --3.2^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   2003-2016   --6.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   36.9    12.7    1999-2003   --2.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   2003-2016   --7.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   14.6   5.0    1999-2003   --4.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2003-2016   --6.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Colon and rectum                                              7.7          8.2    1999-2004   5.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2004-2016   --1.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   10.5    11.1    1999-2010   1.9^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2010-2016   --3.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   6.0    5.9    1999-2004   5.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^      2004-2016   --2.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Liver                                                         20.4         11.7   1999-2002   1.0                                                     2002-2016   --3.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   35.3    19.2    1999-2002   0.2                                                     2002-2016   --3.9^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   8.3    5.2    1999-2002   2.9                                                      2002-2016   --3.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn11-crt-2019-138){ref-type="table-fn"}^   5.2          4.2    1999-2001   6.9                                                     2001-2016   --2.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   6.8     5.3     1999-2001   5.5                                                     2001-2016   --2.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   4.1    3.4    1999-2001   9.0                                                      2001-2016   --2.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Pancreas                                                      5.4          5.7    1999-2016   0.3^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      7.6     7.0     1999-2016   --0.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      3.9    4.6    1999-2016   0.9^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^      \-          \-
  Larynx                                                        1.6          0.3    1999-2016   --9.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      3.4     0.8     1999-2016   --9.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      0.4    0.0    1999-2010   --15.3^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   2010-2016   --8.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Lung                                                          22.4         17.6   1999-2002   1.9                                                     2002-2016   --2.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   41.5    31.2    1999-2001   4.3                                                     2001-2016   --2.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   9.4    7.7    1999-2002   2.6                                                      2002-2016   --1.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Breast                                                        2.2          2.9    1999-2016   1.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     \-          \-                                                      0.1     0.0     1999-2016   --4.3^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      4.2    5.5    1999-2016   1.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^      \-          \-
  Cervix uteri                                                  1.4          1.0    1999-2003   8.3^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2003-2016   --5.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-      \-      \-          \-                                                      \-          \-                                                      2.6    1.8    1999-2003   7.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^      2003-2016   --4.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Corpus uteri                                                  0.1          0.4    1999-2002   52.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2002-2016   3.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     \-      \-      \-          \-                                                      \-          \-                                                      0.1    0.7    1999-2002   51.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2002-2016   3.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Ovary                                                         0.9          1.3    1999-2001   10.2                                                    2001-2016   0.4                                                     \-      \-      \-          \-                                                      \-          \-                                                      1.7    2.5    1999-2006   1.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^      \-          \-
  Prostate                                                      0.9          1.5    1999-2004   9.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2004-2016   0.1                                                     2.6     4.2     1999-2004   9.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2002-2016   --0.4                                                   \-     \-     \-          \-                                                       \-          \-
  Testis                                                        0.0          0.0    1999-2016   --2.6                                                   \-          \-                                                      0.1     0.0     1999-2016   --3.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      \-     \-     \-          \-                                                       \-          \-
  Kidney                                                        1.1          1.1    1999-2016   --0.1                                                   \-          \-                                                      1.8     1.8     1999-2016   0.0                                                     \-          \-                                                      0.5    0.5    1999-2016   --0.7                                                    \-          \-
  Bladder                                                       1.3          1.3    1999-2011   10.0                                                    2011-2016   --1.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   2.6     2.5     1999-2016   --1.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      0.5    0.5    1999-2001   10.3                                                     2001-2016   --1.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Brain and CNS                                                 1.9          1.7    1999-2002   4.2                                                     2002-2016   --1.9^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   2.2     2.0     1999-2016   --1.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      1.6    1.4    1999-2016   --1.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    \-          \-
  Thyroid                                                       0.4          0.3    1999-2003   7.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2003-2016   --4.4^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   0.3     0.2     1999-2003   10.3                                                    2003-2016   --4.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   0.5    0.4    1999-2004   4.5                                                      2004-2016   --4.9^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^
  Hodgkin lymphoma                                              0.0          0.1    1999-2004   22.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2004-2016   --1.4                                                   0.0     0.1     1999-2004   19.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2004-2016   --2.3                                                   0.0    0.0    1999-2003   43.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^     2003-2016   0.0
  Non-Hodgkin lymphoma                                          2.1          1.9    1999-2016   --0.5^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      3.0     2.6     1999-2016   --0.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      1.4    1.4    1999-2016   --0.2                                                    \-          \-
  Multiple myeloma                                              0.6          1.0    1999-2003   12.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2003-2016   0.9                                                     0.8     1.2     1999-2003   11.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2003-2016   0.8                                                     0.4    0.9    1999-2005   9.8^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^      2005-2016   0.3
  Leukemia                                                      2.9          2.3    1999-2016   --1.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      3.5     2.8     1999-2016   --1.6^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      2.4    1.9    1999-2016   --1.9^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^                
  Other and ill-defined                                         7.8          4.3    1999-2016   --3.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   \-          \-                                                      9.0     5.3     1999-2008   --0.3                                                   2009-2016   --5.7^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^   7.0    3.5    1999-2005   --7.0^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^    2005-2016   --2.1^[a)](#tfn10-crt-2019-138){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the Segi's world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The five common sites of cancer incidence by age group and sex in Korea, 2016

  Rank        Age (yr)                                                                            
  ----------- ---------------------------- ---------------------------- ------------------------- --------------------------
  **Men**                                                                                         
   1          Leukemia (5.2)               Thyroid (13.7)               Stomach (85.6)            Lung (435.1)
   2          Non-Hodgkin lymphoma (2.9)   Leukemia (3.8)               Colon and rectum (65.1)   Stomach (353.1)
   3          Brain and CNS (2.3)          Non-Hodgkin lymphoma (3.1)   Liver (55.6)              Prostate (313.4)
   4          Kidney (0.6)                 Colon and rectum (2.6)       Lung (44.0)               Colon and rectum (302.6)
   5          Liver (0.4)                  Testis (2.3)                 Thyroid (33.3)            Liver (175.5)
  **Women**                                                                                       
   1          Leukemia (4.5)               Thyroid (50.5)               Breast (147.5)            Colon and rectum (175.2)
   2          Brain and CNS (2.0)          Breast (12.0)                Thyroid (127.9)           Stomach (137.2)
   3          Non-Hodgkin lymphoma (1.2)   Cervix uteri (5.7)           Colon and rectum (37.6)   Lung (126.8)
   4          Ovary (0.5)                  Ovary (3.3)                  Stomach (37.6)            Breast (89.5)
   5          Kidney (0.4)                 Leukemia (2.8)               Lung (24.9)               Liver (65.6)

CNS, central nervous system.

###### 

Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2016 in Korea

  Site/Type                                                     Both sexes   Men    Women                                                                                                                                 
  ------------------------------------------------------------- ------------ ------ ------- ------ ------- ------- ------ ------ ------ ------ ------- ------- ------- ------ ------ ------ ------ ------ ------- ------- ------
  All sites                                                     41.2         44.0   54.0    65.2   70.7    70.6    29.4   31.7   35.3   45.4   56.6    62.9    63.2    31.5   53.4   55.3   64.2   74.3   78.3    78.0    24.6
  Lip, oral cavity, and pharynx                                 41.1         46.7   54.3    60.8   64.9    65.4    24.3   35.8   41.1   49.5   56.7    61.3    62.1    26.3   58.1   63.8   67.9   71.8   74.2    73.9    15.8
  Esophagus                                                     12.7         15.2   21.4    29.7   36.4    37.4    24.7   11.8   14.3   20.6   29.1    36.1    37.2    25.4   23.7   24.2   29.8   36.9   39.4    39.6    15.9
  Stomach                                                       42.8         46.6   57.8    68.1   75.7    76.0    33.2   43.0   46.9   58.5   68.8    76.6    76.9    33.9   42.6   46.0   56.5   66.8   73.8    73.9    31.3
  Colon and rectum                                              54.8         58.0   66.7    73.6   76.2    75.9    21.1   55.3   59.0   68.6   75.5    77.9    77.8    22.5   54.2   56.8   64.3   70.8   73.6    73.2    19.0
  Liver                                                         10.7         13.2   20.4    28.1   34.0    34.6    23.9   9.9    12.9   20.3   28.1    34.5    35.2    25.3   13.6   14.2   20.9   28.2   32.6    32.7    19.1
  Gallbladder^[b)](#tfn13-crt-2019-138){ref-type="table-fn"}^   17.3         19.7   23.0    26.7   28.8    29.0    11.7   16.6   20.3   23.4   27.6    29.5    29.7    13.1   18.0   19.1   22.6   25.8   28.0    28.3    10.3
  Pancreas                                                      9.4          7.6    8.4     8.4    10.7    11.4    2.0    8.8    7.3    8.4    8.2     10.3    11.2    2.4    10.1   8.1    8.4    8.7    11.2    11.7    1.6
  Larynx                                                        59.7         62.3   66.2    72.8   75.2    75.7    16.0   60.2   62.8   66.8   73.1    75.7    76.3    16.1   55.4   57.8   58.5   67.7   67.9    65.8    10.4
  Lung                                                          11.3         12.7   16.5    20.1   27.1    28.2    16.9   10.4   11.6   15.2   17.9    23.0    23.7    13.3   14.2   16.2   20.1   25.8   36.5    38.6    24.4
  Breast                                                        77.9         83.2   88.6    91.1   92.5    92.7    14.8   75.1   85.6   87.2   89.5    86.3    89.3    14.2   78.0   83.2   88.6   91.1   92.6    92.7    14.7
  Cervix uteri                                                  77.5         80.0   81.4    80.6   80.1    79.8    2.3    \-     \-     \-     \-      \-      \-      \-     77.5   80.0   81.4   80.6   80.1    79.8    2.3
  Corpus uteri                                                  81.5         81.8   84.7    86.4   87.8    87.5    6.0    \-     \-     \-     \-      \-      \-      \-     81.5   81.8   84.7   86.4   87.8    87.5    6.0
  Ovary                                                         58.7         58.9   61.6    61.1   63.9    64.0    5.3    \-     \-     \-     \-      \-      \-      \-     58.7   58.9   61.6   61.1   63.9    64.0    5.3
  Prostate                                                      55.9         67.2   80.4    91.1   94.0    93.9    38.0   55.9   67.2   80.4   91.1    94.0    93.9    38.0   \-     \-     \-     \-     \-      \-      \-
  Testis                                                        85.4         90.4   90.7    93.1   95.3    95.2    9.8    85.4   90.4   90.7   93.1    95.3    95.2    9.8    \-     \-     \-     \-     \-      \-      \-
  Kidney                                                        62.0         66.1   73.5    78.3   82.3    82.7    20.7   60.8   64.4   72.9   78.2    81.8    82.5    21.7   64.5   69.7   74.8   78.7   83.3    83.1    18.6
  Bladder                                                       69.1         73.1   75.7    76.6   76.0    76.0    6.9    70.0   74.8   77.4   78.6    77.9    78.0    8.0    65.5   66.3   68.8   68.6   68.1    68.1    2.6
  Brain and CNS                                                 38.5         39.0   41.0    42.8   41.1    41.4    2.9    37.2   37.5   40.2   41.3    39.4    39.3    2.1    40.2   40.7   41.8   44.4   43.1    43.9    3.7
  Thyroid                                                       94.2         94.9   98.3    99.9   100.2   100.2   6.0    87.2   89.5   95.9   100.0   100.6   100.5   13.3   95.4   95.9   98.7   99.9   100.1   100.1   4.7
  Hodgkin lymphoma                                              68.0         71.2   76.6    80.9   82.3    83.0    15.0   67.6   68.1   74.6   80.7    82.2    81.9    14.3   68.6   77.4   80.7   81.4   82.5    85.0    16.4
  Non-Hodgkin lymphoma                                          46.6         50.8   55.9    59.3   62.7    63.1    16.5   45.3   48.9   54.9   59.0    62.7    63.2    17.9   48.7   53.5   57.4   59.6   62.8    63.0    14.3
  Multiple myeloma                                              22.1         19.8   29.6    34.9   41.1    41.9    19.8   21.1   17.8   29.7   35.0    40.3    40.3    19.2   23.3   22.1   29.4   34.8   41.9    43.6    20.3
  Leukemia                                                      26.5         33.3   41.9    47.6   51.5    51.9    25.4   26.2   32.3   41.8   46.9    51.8    52.5    26.3   26.8   34.6   42.2   48.6   51.1    51.1    24.3
  Other and ill-defined                                         42.1         45.9   57.6    67.2   72.4    73.3    31.2   37.4   42.4   53.8   63.4    69.1    70.1    32.7   47.4   50.0   61.7   71.1   75.7    76.4    29.0

CNS, central nervous system.

Percentage change in 5-year relative survival from 1993 to 1995 and 2012 to 2016,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2017 in Korea

  Site/Type                                                     Crude prevalence rate per 100,000^[a)](#tfn14-crt-2019-138){ref-type="table-fn"}^   Age-standardized prevalence rate per 100,000^[b)](#tfn15-crt-2019-138){ref-type="table-fn"}^                                 
  ------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------- --------- --------- ---------
  All sites                                                     3,404.1                                                                             2,993.2                                                                                        3,814.1   2,046.2   1,896.1   2,281.5
  Lip, oral cavity, and pharynx                                 46.2                                                                                62.1                                                                                           30.5      28.2      39.7      18.2
  Esophagus                                                     19.1                                                                                34.4                                                                                           3.9       10.5      20.9      1.9
  Stomach                                                       535.5                                                                               709.9                                                                                          361.4     297.8     433.6     185.7
  Colon and rectum                                              462.6                                                                               551.8                                                                                          373.6     254.8     338.9     186.9
  Liver                                                         126.9                                                                               190.6                                                                                          63.3      74.7      119.1     34.6
  Gallbladder^[c)](#tfn16-crt-2019-138){ref-type="table-fn"}^   41.1                                                                                42.2                                                                                           40.0      21.8      25.6      18.9
  Pancreas                                                      20.7                                                                                21.6                                                                                           19.9      11.9      13.5      10.6
  Larynx                                                        20.6                                                                                38.8                                                                                           2.4       11.2      23.6      1.2
  Lung                                                          149.8                                                                               185.8                                                                                          113.8     82.7      113.6     58.9
  Breast                                                        387.4                                                                               2.9                                                                                            771.0     239.0     1.8       470.0
  Cervix uteri                                                  103.2                                                                               \-                                                                                             206.2     62.6      \-        122.3
  Corpus uteri                                                  45.3                                                                                \-                                                                                             90.4      28.0      \-        55.1
  Ovary                                                         38.2                                                                                \-                                                                                             76.3      25.5      \-        50.6
  Prostate                                                      151.9                                                                               304.1                                                                                          \-        76.1      180.5     \-
  Testis                                                        6.3                                                                                 12.6                                                                                           \-        5.7       11.1      \-
  Kidney                                                        76.0                                                                                102.5                                                                                          49.5      46.3      65.8      29.0
  Bladder                                                       65.6                                                                                107.1                                                                                          24.2      34.4      65.2      10.9
  Brain and CNS                                                 21.7                                                                                22.5                                                                                           21.0      18.3      19.5      17.1
  Thyroid                                                       743.3                                                                               255.9                                                                                          1,229.7   487.5     171.0     801.9
  Hodgkin lymphoma                                              5.5                                                                                 6.9                                                                                            4.1       4.5       5.5       3.5
  Non-Hodgkin lymphoma                                          58.9                                                                                67.1                                                                                           50.7      40.8      49.1      33.1
  Multiple myeloma                                              11.3                                                                                11.9                                                                                           10.7      6.4       7.3       5.7
  Leukemia                                                      40.6                                                                                45.3                                                                                           36.0      37.4      41.8      33.0
  Other and ill-defined                                         226.4                                                                               217.1                                                                                          235.6     139.9     149.0     132.6

CNS, central nervous system.

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2016 and who were alive on January 1, 2017. Multiple primary cancer cases were counted multiple times,

Age-adjusted using the Segi's world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

[^1]: The members of the group are listed at the end of this article.
